These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 33125946)

  • 1. Repurposing anticancer drugs for the management of COVID-19.
    El Bairi K; Trapani D; Petrillo A; Le Page C; Zbakh H; Daniele B; Belbaraka R; Curigliano G; Afqir S
    Eur J Cancer; 2020 Dec; 141():40-61. PubMed ID: 33125946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repositioning of Drugs to Counter COVID-19 Pandemic - An Insight.
    Akilesh SM; J R; Palanisamy D; Wadhwani A
    Curr Pharm Biotechnol; 2021; 22(2):192-199. PubMed ID: 32867651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug repurposing approach to combating coronavirus: Potential drugs and drug targets.
    Xu J; Xue Y; Zhou R; Shi PY; Li H; Zhou J
    Med Res Rev; 2021 May; 41(3):1375-1426. PubMed ID: 33277927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing of Anticancer Drugs Expands Possibilities for Antiviral and Anti-Inflammatory Discovery in COVID-19.
    Aldea M; Michot JM; Danlos FX; Ribas A; Soria JC
    Cancer Discov; 2021 Jun; 11(6):1336-1344. PubMed ID: 33846172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of repurposed antiviral drugs: Lessons from COVID-19.
    Martinez MA
    Drug Discov Today; 2022 Jul; 27(7):1954-1960. PubMed ID: 35192924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval.
    Ashour NA; Abo Elmaaty A; Sarhan AA; Elkaeed EB; Moussa AM; Erfan IA; Al-Karmalawy AA
    Drug Des Devel Ther; 2022; 16():685-715. PubMed ID: 35321497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review.
    Mohamed K; Yazdanpanah N; Saghazadeh A; Rezaei N
    Bioorg Chem; 2021 Jan; 106():104490. PubMed ID: 33261845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV.
    Aherfi S; Pradines B; Devaux C; Honore S; Colson P; Scola B; Raoult D
    Future Microbiol; 2021 Nov; 16():1341-1370. PubMed ID: 34755538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-molecule Antiviral Agents in Ongoing Clinical Trials for COVID-19.
    Apaydın ÇB; Çınar G; Cihan-Üstündağ G
    Curr Drug Targets; 2021; 22(17):1986-2005. PubMed ID: 33588727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
    Kumar P; Sah AK; Tripathi G; Kashyap A; Tripathi A; Rao R; Mishra PC; Mallick K; Husain A; Kashyap MK
    Mol Cell Biochem; 2021 Feb; 476(2):553-574. PubMed ID: 33029696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches.
    Watashi K
    Biochem Biophys Res Commun; 2021 Jan; 538():137-144. PubMed ID: 33272566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing drugs for the management of COVID-19.
    Cusinato J; Cau Y; Calvani AM; Mori M
    Expert Opin Ther Pat; 2021 Apr; 31(4):295-307. PubMed ID: 33283567
    [No Abstract]   [Full Text] [Related]  

  • 13. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
    Fiscon G; Conte F; Farina L; Paci P
    PLoS Comput Biol; 2021 Feb; 17(2):e1008686. PubMed ID: 33544720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Approaches of Repositioning and Traditional Drugs for the Treatment of COVID-19 Pandemic Outbreak.
    Tandon N; Luxami V; Tandon R; Paul K
    Mini Rev Med Chem; 2021; 21(8):952-968. PubMed ID: 33234101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19: Vaccine Delivery System, Drug Repurposing and Application of Molecular Modeling Approach.
    Abd El Hadi SR; Zien El-Deen EE; Bahaa MM; Sadakah AA; Yassin HA
    Drug Des Devel Ther; 2021; 15():3313-3330. PubMed ID: 34366663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing therapeutic agents against SARS-CoV-2 infection: most promising and neoteric progress.
    Hossain MJ; Rahman SMA
    Expert Rev Anti Infect Ther; 2021 Aug; 19(8):1009-1027. PubMed ID: 33355520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facts and Myths: Efficacies of Repurposing Chloroquine and Hydroxychloroquine for the Treatment of COVID-19.
    Al-Bari AA
    Curr Drug Targets; 2020; 21(16):1703-1721. PubMed ID: 32552642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reactions associated with COVID-19 management.
    Chavda V; Dodiya P; Apostolopoulos V
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Oct; 397(10):7353-7376. PubMed ID: 38743117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug repurposing against COVID-19: focus on anticancer agents.
    Ciliberto G; Mancini R; Paggi MG
    J Exp Clin Cancer Res; 2020 May; 39(1):86. PubMed ID: 32398164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transferable deep learning approach to fast screen potential antiviral drugs against SARS-CoV-2.
    Wang S; Sun Q; Xu Y; Pei J; Lai L
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34081143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.